Summary

The global Anti-Aging Drugs and Devices market size was US$ 31290 million in 2025 and is forecast to reach a readjusted size of US$ 55660 million by 2032 with a CAGR of 8.7% during the forecast period 2026-2032.
Botox and filler treatments are into the drift. Botox encompasses purified bacteria that freezes muscles. In doing so, Botox can help minimalize the appearance of wrinkles and lines caused by facial fillers and expressions contain elements that add plumpness to areas that have thinned due to aging.
The Anti-Aging Drugs and Devices market is experiencing robust growth driven by the global rise in the aging population, increased health awareness, and growing demand for aesthetic enhancement and preventive healthcare. Technological advancements—such as innovations in senolytic therapies, NAD+ boosters, and non-invasive aesthetic devices—have expanded both the clinical and consumer segments. High disposable incomes, particularly in developed and emerging markets, are fueling demand for both prescription drugs and high-end anti-aging equipment. Moreover, the rise of telemedicine, personalized treatment protocols, and wellness-focused lifestyles are encouraging individuals to invest in products that promise longevity and improved quality of life.
Despite strong demand, the market faces several significant challenges. Anti-aging drugs often lack long-term clinical validation and face regulatory hurdles, as aging is not officially classified as a disease by most health authorities. This limits funding, insurance coverage, and product approvals. On the device side, high costs, limited accessibility in low-income regions, and the need for professional operation can restrict market penetration. Additionally, skepticism around the safety and efficacy of certain products, along with varying global regulations and ethical concerns surrounding age-delaying interventions, further complicate commercial expansion and consumer adoption.
The global Anti-Aging Drugs and Devices market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
AbbVie
Galderma
LG Life Sciences
Merz
Medytox
Hugel
Croma-Pharma
Beijing IMEIK
Bloomage Bio
Elravie (Humedix)
Cleviel (Pharma Research Products)
Haohai Biological
Teoxane
Sinclair
Suneva Medical
CG Bio
SciVision Biotech
Prollenium
Ipsen
Alma
Solta Medical
Cutera
Lumenis
Cynosure
Syneron Candela
YA-MAN
NUFACE
FOREO
Hitachi Medical
Philips
Segment by Type
Drugs
Devices
Segment by Application
Hospital
Beauty Salon
Home
By Region
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Markets
North America
Europe
China
Japan
(Additional regions can be customized based on client needs.)
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of Anti-Aging Drugs and Devices market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Anti-Aging Drugs and Devices value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Drugs
1.2.3 Devices
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Beauty Salon
1.3.4 Home
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-Aging Drugs and Devices Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Anti-Aging Drugs and Devices Market Share by Revenue, by Region (2021-2026)
2.4 Global Anti-Aging Drugs and Devices Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Anti-Aging Drugs and Devices Market Size and Prospective (2021-2032)
2.5.2 Europe Anti-Aging Drugs and Devices Market Size and Prospective (2021-2032)
2.5.3 China Anti-Aging Drugs and Devices Market Size and Prospective (2021-2032)
2.5.4 Japan Anti-Aging Drugs and Devices Market Size and Prospective (2021-2032)
3 Breakdown Data by Type
3.1 Global Anti-Aging Drugs and Devices Historical Market Size by Type (2021-2026)
3.2 Global Anti-Aging Drugs and Devices Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Anti-Aging Drugs and Devices
4 Breakdown Data by Application
4.1 Global Anti-Aging Drugs and Devices Historical Market Size by Application (2021-2026)
4.2 Global Anti-Aging Drugs and Devices Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Anti-Aging Drugs and Devices Applications
5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Anti-Aging Drugs and Devices Players by Revenue (2021-2026)
5.1.2 Global Anti-Aging Drugs and Devices Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Anti-Aging Drugs and Devices Revenue
5.4 Global Anti-Aging Drugs and Devices Market Concentration Analysis
5.4.1 Global Anti-Aging Drugs and Devices Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Anti-Aging Drugs and Devices Revenue in 2025
5.5 Global Key Players of Anti-Aging Drugs and Devices Head Offices and Areas Served
5.6 Global Key Players of Anti-Aging Drugs and Devices, Product and Application
5.7 Global Key Players of Anti-Aging Drugs and Devices, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Anti-Aging Drugs and Devices Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Anti-Aging Drugs and Devices Market Size by Type (2021-2026)
6.1.2.2 North America Anti-Aging Drugs and Devices Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Anti-Aging Drugs and Devices Market Size by Application (2021-2026)
6.1.3.2 North America Anti-Aging Drugs and Devices Market Share by Application (2021-2026)
6.1.4 North America Anti-Aging Drugs and Devices Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Anti-Aging Drugs and Devices Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Anti-Aging Drugs and Devices Market Size by Type (2021-2026)
6.2.2.2 Europe Anti-Aging Drugs and Devices Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Anti-Aging Drugs and Devices Market Size by Application (2021-2026)
6.2.3.2 Europe Anti-Aging Drugs and Devices Market Share by Application (2021-2026)
6.2.4 Europe Anti-Aging Drugs and Devices Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Anti-Aging Drugs and Devices Revenue by Company (2021-2026)
6.3.2 China Market Size by Type
6.3.2.1 China Anti-Aging Drugs and Devices Market Size by Type (2021-2026)
6.3.2.2 China Anti-Aging Drugs and Devices Market Share by Type (2021-2026)
6.3.3 China Market Size by Application
6.3.3.1 China Anti-Aging Drugs and Devices Market Size by Application (2021-2026)
6.3.3.2 China Anti-Aging Drugs and Devices Market Share by Application (2021-2026)
6.3.4 China Anti-Aging Drugs and Devices Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Anti-Aging Drugs and Devices Revenue by Company (2021-2026)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Anti-Aging Drugs and Devices Market Size by Type (2021-2026)
6.4.2.2 Japan Anti-Aging Drugs and Devices Market Share by Type (2021-2026)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Anti-Aging Drugs and Devices Market Size by Application (2021-2026)
6.4.3.2 Japan Anti-Aging Drugs and Devices Market Share by Application (2021-2026)
6.4.4 Japan Anti-Aging Drugs and Devices Major Customers
6.4.5 Japan Market Trends and Opportunities
7 Key Player Profiles
7.1 AbbVie
7.1.1 AbbVie Company Details
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Anti-Aging Drugs and Devices Introduction
7.1.4 AbbVie Revenue in Anti-Aging Drugs and Devices Business (2021-2026)
7.1.5 AbbVie Recent Development
7.2 Galderma
7.2.1 Galderma Company Details
7.2.2 Galderma Business Overview
7.2.3 Galderma Anti-Aging Drugs and Devices Introduction
7.2.4 Galderma Revenue in Anti-Aging Drugs and Devices Business (2021-2026)
7.2.5 Galderma Recent Development
7.3 LG Life Sciences
7.3.1 LG Life Sciences Company Details
7.3.2 LG Life Sciences Business Overview
7.3.3 LG Life Sciences Anti-Aging Drugs and Devices Introduction
7.3.4 LG Life Sciences Revenue in Anti-Aging Drugs and Devices Business (2021-2026)
7.3.5 LG Life Sciences Recent Development
7.4 Merz
7.4.1 Merz Company Details
7.4.2 Merz Business Overview
7.4.3 Merz Anti-Aging Drugs and Devices Introduction
7.4.4 Merz Revenue in Anti-Aging Drugs and Devices Business (2021-2026)
7.4.5 Merz Recent Development
7.5 Medytox
7.5.1 Medytox Company Details
7.5.2 Medytox Business Overview
7.5.3 Medytox Anti-Aging Drugs and Devices Introduction
7.5.4 Medytox Revenue in Anti-Aging Drugs and Devices Business (2021-2026)
7.5.5 Medytox Recent Development
7.6 Hugel
7.6.1 Hugel Company Details
7.6.2 Hugel Business Overview
7.6.3 Hugel Anti-Aging Drugs and Devices Introduction
7.6.4 Hugel Revenue in Anti-Aging Drugs and Devices Business (2021-2026)
7.6.5 Hugel Recent Development
7.7 Croma-Pharma
7.7.1 Croma-Pharma Company Details
7.7.2 Croma-Pharma Business Overview
7.7.3 Croma-Pharma Anti-Aging Drugs and Devices Introduction
7.7.4 Croma-Pharma Revenue in Anti-Aging Drugs and Devices Business (2021-2026)
7.7.5 Croma-Pharma Recent Development
7.8 Beijing IMEIK
7.8.1 Beijing IMEIK Company Details
7.8.2 Beijing IMEIK Business Overview
7.8.3 Beijing IMEIK Anti-Aging Drugs and Devices Introduction
7.8.4 Beijing IMEIK Revenue in Anti-Aging Drugs and Devices Business (2021-2026)
7.8.5 Beijing IMEIK Recent Development
7.9 Bloomage Bio
7.9.1 Bloomage Bio Company Details
7.9.2 Bloomage Bio Business Overview
7.9.3 Bloomage Bio Anti-Aging Drugs and Devices Introduction
7.9.4 Bloomage Bio Revenue in Anti-Aging Drugs and Devices Business (2021-2026)
7.9.5 Bloomage Bio Recent Development
7.10 Elravie (Humedix)
7.10.1 Elravie (Humedix) Company Details
7.10.2 Elravie (Humedix) Business Overview
7.10.3 Elravie (Humedix) Anti-Aging Drugs and Devices Introduction
7.10.4 Elravie (Humedix) Revenue in Anti-Aging Drugs and Devices Business (2021-2026)
7.10.5 Elravie (Humedix) Recent Development
7.11 Cleviel (Pharma Research Products)
7.11.1 Cleviel (Pharma Research Products) Company Details
7.11.2 Cleviel (Pharma Research Products) Business Overview
7.11.3 Cleviel (Pharma Research Products) Anti-Aging Drugs and Devices Introduction
7.11.4 Cleviel (Pharma Research Products) Revenue in Anti-Aging Drugs and Devices Business (2021-2026)
7.11.5 Cleviel (Pharma Research Products) Recent Development
7.12 Haohai Biological
7.12.1 Haohai Biological Company Details
7.12.2 Haohai Biological Business Overview
7.12.3 Haohai Biological Anti-Aging Drugs and Devices Introduction
7.12.4 Haohai Biological Revenue in Anti-Aging Drugs and Devices Business (2021-2026)
7.12.5 Haohai Biological Recent Development
7.13 Teoxane
7.13.1 Teoxane Company Details
7.13.2 Teoxane Business Overview
7.13.3 Teoxane Anti-Aging Drugs and Devices Introduction
7.13.4 Teoxane Revenue in Anti-Aging Drugs and Devices Business (2021-2026)
7.13.5 Teoxane Recent Development
7.14 Sinclair
7.14.1 Sinclair Company Details
7.14.2 Sinclair Business Overview
7.14.3 Sinclair Anti-Aging Drugs and Devices Introduction
7.14.4 Sinclair Revenue in Anti-Aging Drugs and Devices Business (2021-2026)
7.14.5 Sinclair Recent Development
7.15 Suneva Medical
7.15.1 Suneva Medical Company Details
7.15.2 Suneva Medical Business Overview
7.15.3 Suneva Medical Anti-Aging Drugs and Devices Introduction
7.15.4 Suneva Medical Revenue in Anti-Aging Drugs and Devices Business (2021-2026)
7.15.5 Suneva Medical Recent Development
7.16 CG Bio
7.16.1 CG Bio Company Details
7.16.2 CG Bio Business Overview
7.16.3 CG Bio Anti-Aging Drugs and Devices Introduction
7.16.4 CG Bio Revenue in Anti-Aging Drugs and Devices Business (2021-2026)
7.16.5 CG Bio Recent Development
7.17 SciVision Biotech
7.17.1 SciVision Biotech Company Details
7.17.2 SciVision Biotech Business Overview
7.17.3 SciVision Biotech Anti-Aging Drugs and Devices Introduction
7.17.4 SciVision Biotech Revenue in Anti-Aging Drugs and Devices Business (2021-2026)
7.17.5 SciVision Biotech Recent Development
7.18 Prollenium
7.18.1 Prollenium Company Details
7.18.2 Prollenium Business Overview
7.18.3 Prollenium Anti-Aging Drugs and Devices Introduction
7.18.4 Prollenium Revenue in Anti-Aging Drugs and Devices Business (2021-2026)
7.18.5 Prollenium Recent Development
7.19 Ipsen
7.19.1 Ipsen Company Details
7.19.2 Ipsen Business Overview
7.19.3 Ipsen Anti-Aging Drugs and Devices Introduction
7.19.4 Ipsen Revenue in Anti-Aging Drugs and Devices Business (2021-2026)
7.19.5 Ipsen Recent Development
7.20 Alma
7.20.1 Alma Company Details
7.20.2 Alma Business Overview
7.20.3 Alma Anti-Aging Drugs and Devices Introduction
7.20.4 Alma Revenue in Anti-Aging Drugs and Devices Business (2021-2026)
7.20.5 Alma Recent Development
7.21 Solta Medical
7.21.1 Solta Medical Company Details
7.21.2 Solta Medical Business Overview
7.21.3 Solta Medical Anti-Aging Drugs and Devices Introduction
7.21.4 Solta Medical Revenue in Anti-Aging Drugs and Devices Business (2021-2026)
7.21.5 Solta Medical Recent Development
7.22 Cutera
7.22.1 Cutera Company Details
7.22.2 Cutera Business Overview
7.22.3 Cutera Anti-Aging Drugs and Devices Introduction
7.22.4 Cutera Revenue in Anti-Aging Drugs and Devices Business (2021-2026)
7.22.5 Cutera Recent Development
7.23 Lumenis
7.23.1 Lumenis Company Details
7.23.2 Lumenis Business Overview
7.23.3 Lumenis Anti-Aging Drugs and Devices Introduction
7.23.4 Lumenis Revenue in Anti-Aging Drugs and Devices Business (2021-2026)
7.23.5 Lumenis Recent Development
7.24 Cynosure
7.24.1 Cynosure Company Details
7.24.2 Cynosure Business Overview
7.24.3 Cynosure Anti-Aging Drugs and Devices Introduction
7.24.4 Cynosure Revenue in Anti-Aging Drugs and Devices Business (2021-2026)
7.24.5 Cynosure Recent Development
7.25 Syneron Candela
7.25.1 Syneron Candela Company Details
7.25.2 Syneron Candela Business Overview
7.25.3 Syneron Candela Anti-Aging Drugs and Devices Introduction
7.25.4 Syneron Candela Revenue in Anti-Aging Drugs and Devices Business (2021-2026)
7.25.5 Syneron Candela Recent Development
7.26 YA-MAN
7.26.1 YA-MAN Company Details
7.26.2 YA-MAN Business Overview
7.26.3 YA-MAN Anti-Aging Drugs and Devices Introduction
7.26.4 YA-MAN Revenue in Anti-Aging Drugs and Devices Business (2021-2026)
7.26.5 YA-MAN Recent Development
7.27 NUFACE
7.27.1 NUFACE Company Details
7.27.2 NUFACE Business Overview
7.27.3 NUFACE Anti-Aging Drugs and Devices Introduction
7.27.4 NUFACE Revenue in Anti-Aging Drugs and Devices Business (2021-2026)
7.27.5 NUFACE Recent Development
7.28 FOREO
7.28.1 FOREO Company Details
7.28.2 FOREO Business Overview
7.28.3 FOREO Anti-Aging Drugs and Devices Introduction
7.28.4 FOREO Revenue in Anti-Aging Drugs and Devices Business (2021-2026)
7.28.5 FOREO Recent Development
7.29 Hitachi Medical
7.29.1 Hitachi Medical Company Details
7.29.2 Hitachi Medical Business Overview
7.29.3 Hitachi Medical Anti-Aging Drugs and Devices Introduction
7.29.4 Hitachi Medical Revenue in Anti-Aging Drugs and Devices Business (2021-2026)
7.29.5 Hitachi Medical Recent Development
7.30 Philips
7.30.1 Philips Company Details
7.30.2 Philips Business Overview
7.30.3 Philips Anti-Aging Drugs and Devices Introduction
7.30.4 Philips Revenue in Anti-Aging Drugs and Devices Business (2021-2026)
7.30.5 Philips Recent Development
8 Anti-Aging Drugs and Devices Market Dynamics
8.1 Anti-Aging Drugs and Devices Industry Trends
8.2 Anti-Aging Drugs and Devices Market Drivers
8.3 Anti-Aging Drugs and Devices Market Challenges
8.4 Anti-Aging Drugs and Devices Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer